BioCentury | Oct 10, 2019
Company News

bluebird tech to jump-start Novo in gene editing for hemophilia

...as an adult,” he said. bluebird acquired the megaTAL technology through its 2014 takeout of Pregenen Inc....
BioCentury | Jul 14, 2014
Company News

bluebird bio Inc, Pregenen deal

...bluebird acquired Pregenen in a stock deal. Pregenen received 408,667 bluebird shares valued at $15.8 million...
...bluebird also paid or assumed about $4.9 million in Pregenen liabilities. The former shareholders of Pregenen...
...NASDAQ:BLUE), Cambridge, Mass. Pregenen Inc. , Seattle, Wash. bluebird acquired Pregenen in a stock deal. Pregenen...
BioCentury | Jul 4, 2011
Company News

Cellectis, Pregenen deal

...Pregenen is a spin-off from the Northwest Genome Engineering Consortium. Cellectis S.A. (Euronext:ALCLS), Romainville, France Pregenen Inc....
Items per page:
1 - 3 of 3
BioCentury | Oct 10, 2019
Company News

bluebird tech to jump-start Novo in gene editing for hemophilia

...as an adult,” he said. bluebird acquired the megaTAL technology through its 2014 takeout of Pregenen Inc....
BioCentury | Jul 14, 2014
Company News

bluebird bio Inc, Pregenen deal

...bluebird acquired Pregenen in a stock deal. Pregenen received 408,667 bluebird shares valued at $15.8 million...
...bluebird also paid or assumed about $4.9 million in Pregenen liabilities. The former shareholders of Pregenen...
...NASDAQ:BLUE), Cambridge, Mass. Pregenen Inc. , Seattle, Wash. bluebird acquired Pregenen in a stock deal. Pregenen...
BioCentury | Jul 4, 2011
Company News

Cellectis, Pregenen deal

...Pregenen is a spin-off from the Northwest Genome Engineering Consortium. Cellectis S.A. (Euronext:ALCLS), Romainville, France Pregenen Inc....
Items per page:
1 - 3 of 3